Cargando…

Surgery for limited stage small cell lung cancer

Small cell lung cancer (SCLC) is an aggressive tumor type characterized by rapid growth and overall poor prognosis. For the past several decades, chemotherapy and radiotherapy have served as the cornerstone of treatment. Recently, however, the role of surgery for early stage disease has gained consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gergen, Anna K., Scott, Christopher D., Mitchell, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656341/
https://www.ncbi.nlm.nih.gov/pubmed/33209467
http://dx.doi.org/10.21037/jtd.2020.03.79
_version_ 1783608361279815680
author Gergen, Anna K.
Scott, Christopher D.
Mitchell, John D.
author_facet Gergen, Anna K.
Scott, Christopher D.
Mitchell, John D.
author_sort Gergen, Anna K.
collection PubMed
description Small cell lung cancer (SCLC) is an aggressive tumor type characterized by rapid growth and overall poor prognosis. For the past several decades, chemotherapy and radiotherapy have served as the cornerstone of treatment. Recently, however, the role of surgery for early stage disease has gained considerable interest. Multiple retrospective and observational studies have shown excellent survival for early stage SCLC treated with surgical resection. We herein review the past and present evidence regarding surgical options for limited stage SCLC.
format Online
Article
Text
id pubmed-7656341
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-76563412020-11-17 Surgery for limited stage small cell lung cancer Gergen, Anna K. Scott, Christopher D. Mitchell, John D. J Thorac Dis Review Article on Small Cell Lung Cancer Small cell lung cancer (SCLC) is an aggressive tumor type characterized by rapid growth and overall poor prognosis. For the past several decades, chemotherapy and radiotherapy have served as the cornerstone of treatment. Recently, however, the role of surgery for early stage disease has gained considerable interest. Multiple retrospective and observational studies have shown excellent survival for early stage SCLC treated with surgical resection. We herein review the past and present evidence regarding surgical options for limited stage SCLC. AME Publishing Company 2020-10 /pmc/articles/PMC7656341/ /pubmed/33209467 http://dx.doi.org/10.21037/jtd.2020.03.79 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Review Article on Small Cell Lung Cancer
Gergen, Anna K.
Scott, Christopher D.
Mitchell, John D.
Surgery for limited stage small cell lung cancer
title Surgery for limited stage small cell lung cancer
title_full Surgery for limited stage small cell lung cancer
title_fullStr Surgery for limited stage small cell lung cancer
title_full_unstemmed Surgery for limited stage small cell lung cancer
title_short Surgery for limited stage small cell lung cancer
title_sort surgery for limited stage small cell lung cancer
topic Review Article on Small Cell Lung Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656341/
https://www.ncbi.nlm.nih.gov/pubmed/33209467
http://dx.doi.org/10.21037/jtd.2020.03.79
work_keys_str_mv AT gergenannak surgeryforlimitedstagesmallcelllungcancer
AT scottchristopherd surgeryforlimitedstagesmallcelllungcancer
AT mitchelljohnd surgeryforlimitedstagesmallcelllungcancer